Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,512 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A systematic review and meta-analysis on the prevalence of stigma in infectious diseases, including COVID-19: a call to action.
Yuan K, Huang XL, Yan W, Zhang YX, Gong YM, Su SZ, Huang YT, Zhong Y, Wang YJ, Yuan Z, Tian SS, Zheng YB, Fan TT, Zhang YJ, Meng SQ, Sun YK, Lin X, Zhang TM, Ran MS, Wong SY, Rüsch N, Shi L, Bao YP, Lu L. Yuan K, et al. Among authors: zhang tm, zhang yx, zhang yj. Mol Psychiatry. 2022 Jan;27(1):19-33. doi: 10.1038/s41380-021-01295-8. Epub 2021 Sep 27. Mol Psychiatry. 2022. PMID: 34580416 Free PMC article.
Career choice and influential factors among medical students majoring in psychiatry in China.
Zhang YJ, Yuan K, Chang SH, Yan W, Que JY, Deng JH, Gong YM, Luo JM, Yang SC, An CX, Kang YM, Xu HS, Wang YM, Zhang LF, Zhang WF, Song YL, Xu DW, Liu HZ, Wang WQ, Liu CX, Yang WQ, Zhou L, Zhao JB, Yu MY, Chen JY, Tang H, Peng J, Zhang XJ, Xu Y, Zhang N, Kuang L, Li ZJ, Wang YH, Shi J, Ran MS, Bao YP, Shi L, Lu L. Zhang YJ, et al. Among authors: zhang n, zhang lf, zhang wf, zhang xj. BMC Med Educ. 2021 Mar 25;21(1):183. doi: 10.1186/s12909-021-02622-x. BMC Med Educ. 2021. PMID: 33766012 Free PMC article.
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.
Jin ZC, Chen JJ, Zhu XL, Duan XH, Xin YJ, Zhong BY, Chen JZ, Tie J, Zhu KS, Zhang L, Huang M, Piao MJ, Li X, Shi HB, Liu RB, Xu AB, Ji F, Wu JB, Shao GL, Li HL, Huang MS, Peng ZY, Ji JS, Yuan CW, Liu XF, Hu ZC, Yang WZ, Yin GW, Huang JH, Ge NJ, Qi X, Zhao Y, Zhou JW, Xu GH, Tu Q, Lin HL, Zhang YJ, Jiang H, Shao HB, Su YJ, Chen TS, Shi BQ, Zhou X, Zhao HT, Zhu HD, Ren ZG, Teng GJ; CHANCE2201 Investigators. Jin ZC, et al. Among authors: zhang yj. EClinicalMedicine. 2024 May 6;72:102622. doi: 10.1016/j.eclinm.2024.102622. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38745965 Free PMC article.
3,512 results